Nishikura has been a pillar of Wistar science for the past 37 years with a career overlapping with the rise and expansion of the RNA biology field, which explores the alternative functions of RNA i…
Early diagnosis and screening are the bedrock for addressing cancer in a timely fashion to improve patient survival, yet laboratory diagnostics are lagging behind and so far, are limited to a few s…
Doug and Peggy Briggs have laid the groundwork to bring emerging scientific stars to Wistar through the Institute’s newly founded Caspar Wistar Fellows Program. It started with a me…
Monsoon season was just around the corner. A 26-year-old man living on the outskirts of a dense South Indian tropical forest became sick with flu-like symptoms. It was early May 2018 in the state o…
It is well established that some cancer risk factors are interconnected to genetics or other unchangeable factors, such as age or gender. We also know that external factors, such as sun exposure, i…
“Hope is a state of mind, not a state of the world. Either we have hope within us or we don’t; it is a dimension of the soul not essentially dependent on some particular observation of the world or…
Wistar scientists advanced a novel anticancer treatment that targets the endoplasmic reticulum (a word you last heard in middle school cell biology) and discovered a new function for the ARID1 prot…
In the beautiful setting of the College of Physicians of Philadelphia, Wistar friends attended this year’s Wistar Party, a celebration of Wistar science that has carried on for decades, and an oppo…
Recently, Wistar had the great honor of bestowing its annual Women & Science’s Helen Dean King Award upon Dr. Mary-Claire King, one of the most esteemed and productive scientists of our time, i…
Along with warmer temperatures and the beautiful blossoming across the city, spring has become synonymous with the Philadelphia Science Festival, a staple and model for similar initiatives in other…
